Absence of TSC1 Accelerates CD8⁺ T cell-mediated Acute Cardiac Allograft Rejection

Area of Science:

• Immunology
• Transplantation Biology
• Genetics

Background:

• Tuberous sclerosis complex (TSC) is an autosomal dominant disorder linked to TSC1 or TSC2 mutations.
• Patients with TSC often need organ transplants due to organ failure.
• The role of TSC1 in T cell-mediated transplant immunity is not well understood.

Purpose of the Study:

• To investigate the impact of TSC1 deficiency in T cells on acute allograft rejection.
• To elucidate the mechanisms by which TSC1 affects T cell responses in transplant immunity.

Main Methods:

• Utilized a mouse cardiac transplantation model.
• Characterized T cell populations, including CD8+ T cells, in allografts.
• Assessed T cell infiltration, proliferation, and gene expression (CXCR3, IFN-γ, Granzyme B).
• Evaluated the efficacy of rapamycin treatment in TSC1-deficient and wild-type recipients.

Main Results:

• Mice with TSC1-deficient T cells exhibited accelerated acute allograft rejection.
• TSC1 deficiency in CD8+ T cells enhanced allograft infiltration and in-situ proliferation.
• TSC1-deficient CD8+ T cells displayed increased proliferation, IFN-γ, and Granzyme B expression post-stimulation.
• Rapamycin treatment was less effective in TSC1-deficient mice, with faster allograft rejection.

Conclusions:

• TSC1 deficiency in T cells significantly accelerates acute allograft rejection.
• Enhanced CD8+ T cell alloreactivity contributes to faster rejection.
• TSC1-deficient recipients may exhibit resistance to mTOR inhibitor-based immunosuppression in transplantation.